About
Technology
Issues
FAQ
Links
Official Page
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
